Brainstorm Cell Therapeutics | BCLI - Market Capitalization


Brainstorm Cell Therapeutics reported $42.2M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Biogen USD 25.82B 5.28B Dec/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 7.77B 1.19B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Mesoblast USD 2.33B 936.82M Dec/2025